Charles Rosier: Flavors.me


            Charles Rosier: Flavors.me

Gaining his scientific Baccalaureate degree (equivalent to A-levels in the UK), Charles Rosier (flavors.me Charles Rosier) was able to attend to further education. He took two years of additional classes in preparation for attaining further French qualifications. It was at Paris’s Fenelon Sainte-Marie where Charles Rosier finished his secondary education.

Charles Rosier’s Chosen Career

Charles Rosier was offered a job at Goldman Sachs (GMS) in 1999. He joined the team and was hired as Managing Director. There are around 2,500 employees employed at BTG Pactual, which has 30 years of experience. Charles Rosier managed the French-speaking markets of France, Belgium and Quebec.

A Glimpse at Charles Rosier’s Life

Environmentally-friendly activities, culture, extreme sports and studies are the things that matter most to him. He switched jobs many times while pursuing his career in the industry as an investment banker. It was in 1991 that Charles Rosier completed his scientific degree at Fenelon Sainte-Marie. In 1996, Charles Rosier began at Lehman Brothers before later becoming a member of UBS Warburg Investment Bank. He then became the head of the finance department at Goldman Sachs Bank.

Positions Charles Rosier Held

BTG Pactual is an investment bank situated in Latin America, with whom Charles Rosier was a partner for years. At BTG Pactual, he imposed five major principles. (Meritocracy and Partnership, World-Class Governance, Customer Focus, Global Thinking Presence and Long Term View). A leading investment bank that operates globally is GMS (Goldman Sachs). Being employed as their Managing Director, he focused on keeping public assets correctly handled. From 1997 to 2009, Charles Rosier worked as the Debt Capital Manager at SBC Warburg. He also worked at Lehman Brothers where he began his dream career as an investment banker.

Because of the investment provided by him, the organisation was able to perform studies and give a percentage of their profit to Charles Rosier. Baulieu and his co-workers were creating a new drug, however they needed more finances to develop such a drug... so he invested in them. The drug project Charles Rosier funded was for the treatment of stroke known to cause spinal cord problems.